BloodPAC
Cancer Moonshot - BloodPAC

Blog

Firm Announcements and Law Updates

Collaborating to Compete: Blood Profiling Atlas in Cancer (BloodPAC) Consortium

Published in Clinical Pharmacology and Theraputics, April 12, 2017

The cancer community understands the value of blood profiling measurements in assessing and monitoring cancer. We describe an effort among academic, government, biotechnology, diagnostic, and pharmaceutical companies called the Blood Profiling Atlas in Cancer (BloodPAC) Project. BloodPAC will aggregate, make freely available, and harmonize for further analyses, raw datasets, relevant associated clinical data (e.g., clinical diagnosis, treatment history, and outcomes), and sample preparation and handling protocols to accelerate the development of blood profiling assays.

Read the full paper: http://onlinelibrary.wiley.com/doi/10.1002/cpt.666/full

Walt Wells